Functional Status and Mortality in Chronic Kidney Disease: Results from a Prospective Observational Study

被引:14
作者
Ritchie, James P. [1 ]
Alderson, Helen [1 ]
Green, Darren [1 ]
Chiu, Diana [1 ]
Sinha, Smeeta [1 ]
Middleton, Rachel [1 ]
O'Donoghue, Donal [1 ]
Kalra, Philip A. [1 ]
机构
[1] Salford Royal Hosp, Manchester Acad Hlth Sci Ctr, Vasc Res Grp, Salford M6 8HD, Lancs, England
来源
NEPHRON CLINICAL PRACTICE | 2014年 / 128卷 / 1-2期
关键词
Functional status; Mortality; Chronic kidney disease; Progression; QUALITY-OF-LIFE; STAGE RENAL-DISEASE; RISK; PROGRESSION; DECLINE; GFR; ASSOCIATION; MARKER;
D O I
10.1159/000362453
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Measures of functional status are used in the general population to aid prognostication but their use has not been explored in pre-dialysis chronic kidney disease (CKD). This analysis considers the association between the Karnofsky performance score (KPS) and all-cause mortality in a CKD stage 3-5 cohort. Methods: Patients were selected from the Chronic Renal Insufficiency Standards Implementation Study (CRISIS), a prospective observational study of outcome in CKD. Risk for death was assessed using multivariate Cox regression, and differences in progression of biochemical parameters were considered in a mixed-effects model. Results: A total of 1,515 patients with a median follow-up time of 2.9 (1.5-4.8) years were considered. Baseline age was 60 +/- 11 years and eGFR was 30 +/- 12 ml/min/1.73 m(2). Patients with a reduced KPS had an increased risk for death. The hazard ratio (HR) for death was: KPS 90 group, HR 1.2 (95% CI 0.9-1.5), p = 0.1; KPS <= 80 group, HR 1.8 (95% CI 1.4-2.4), p < 0.001. In the mixed-effects model, the average annual loss of eGFR was greater in patients with a KPS <= 80 versus patients with a KPS >80 (5 vs. 3%, p = 0.008). Conclusion: A reduced KPS is independently associated with risk for mortality in patients with CKD stages 3-5. This may relate to a more rapid loss of eGFR. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:22 / 28
页数:7
相关论文
共 50 条
  • [21] Effects of CYP3A5 Polymorphism on Rapid Progression of Chronic Kidney Disease: A Prospective, Multicentre Study
    Lee, Fei Yee
    Islahudin, Farida
    Ali Nasiruddin, Aina Yazrin
    Abdul Gafor, Abdul Halim
    Wong, Hin-Seng
    Bavanandan, Sunita
    Mohd Saffian, Shamin
    Md Redzuan, Adyani
    Mohd Tahir, Nurul Ain
    Makmor-Bakry, Mohd
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (04):
  • [22] Epidemiology of chronic kidney disease: Results from a population of older adults in Germany
    Zhang, Qiu-Li
    Koenig, Wolfgang
    Raum, Elke
    Stegmaier, Christa
    Brenner, Hermann
    Rothenbacher, Dietrich
    PREVENTIVE MEDICINE, 2009, 48 (02) : 122 - 127
  • [23] Chronic Kidney Disease in Panama: Results From the PREFREC Study and National Mortality Trends
    Moreno Velasquez, Ilais
    Castro, Franz
    Gomez, Beatriz
    Cuero, Cesar
    Motta, Jorge
    KIDNEY INTERNATIONAL REPORTS, 2017, 2 (06): : 1032 - 1041
  • [24] Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study
    Reichel, Helmut
    Zee, Jarcy
    Tu, Charlotte
    Young, Eric
    Pisoni, Ronald L.
    Stengel, Benedicte
    Duttlinger, Johannes
    Lonnemann, Gerhard
    Robinson, Bruce M.
    Pecoits-Filho, Roberto
    Fliser, Danilo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (05) : 803 - 810
  • [25] Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study
    Lindhardt, Morten
    Knudsen, Soren Tang
    Saxild, Thomas
    Charles, Morten
    Borg, Rikke
    BMC PRIMARY CARE, 2025, 26 (01):
  • [26] Intensity of statin therapy and renal outcome in chronic kidney disease: Results from the Korean Cohort Study for Outcome in Patients With Chronic Kidney Disease
    Jhee, Jong Hyun
    Joo, Young Su
    Park, Jung Tak
    Yoo, Tae-Hyun
    Park, Sue Kyung
    Jung, Ji Yong
    Kim, Soo Wan
    Oh, Yun Kyu
    Oh, Kook-Hwan
    Kang, Shin-Wook
    Choi, Kyu Hun
    Ahn, Curie
    Han, Seung Hyeok
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2020, 39 (01) : 93 - 102
  • [27] Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE Study
    Cozzolino, Mario
    Bolasco, Piergiorgio
    Ronco, Claudio
    Conte, Giuseppe
    Mene, Paolo
    Mereu, Maria Cristina
    Di Luca, Marina
    Roccatello, Dario
    Rosati, Alberto
    Jommi, Claudio
    Costanzo, Anna Maria
    Gualberti, Giuliana
    Paparatti, Umberto di Luzio
    Remuzzi, Giuseppe
    NEPHRON, 2018, 140 (01) : 39 - 47
  • [28] Results from the German Chronic Kidney Disease (GCKD) study support association of relative telomere length with mortality in a large cohort of patients with moderate chronic kidney disease
    Fazzini, Federica
    Lamina, Claudia
    Raschenberger, Julia
    Schultheiss, Ulla T.
    Kotsis, Fruzsina
    Schoenherr, Sebastian
    Weissensteiner, Hansi
    Forer, Lukas
    Steinbrenner, Inga
    Meiselbach, Heike
    Baerthlein, Barbara
    Wanner, Christoph
    Eckardt, Kai-Uwe
    Koettgen, Anna
    Kronenberg, Florian
    KIDNEY INTERNATIONAL, 2020, 98 (02) : 488 - 497
  • [29] Effect of sodium bicarbonate on cardiovascular outcome and mortality in patients with advanced chronic kidney disease
    Cheng, Ya-Lien
    Huang, Shu-Chun
    Ho, Ming-Yun
    Li, Yan-Rong
    Yen, Chieh-Li
    Chen, Kuan-Hsing
    Sun, Wei-Chiao
    Fan, Pei-Yi
    Chen, Jung-Sheng
    Lin, Chihung
    Hsiao, Ching-Chung
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [30] Associations of low-carbohydrate with mortality in chronic kidney disease
    Ren, Qidong
    Zhou, Yangzhong
    Luo, Huiting
    Chen, Gang
    Han, Yan
    Zheng, Ke
    Qin, Yan
    Li, Xuemei
    RENAL FAILURE, 2023, 45 (01)